The management of patients with patent foramen ovale and stroke
- Irene Meissner MD, FRCP(C)
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The management of patients with patent foramen ovale (PFO) and stroke remains uncertain. What is known is that PFO is a very common finding in the general population. The risk of initial and recurrent stroke in individuals with PFO is relatively low. With the advent of transesophageal echocardiography, PFO is more commonly being diagnosed. There are insufficient data to support a benefit of warfarin over aspirin in preventing recurrent stroke in most patients with PFO. In those with PFO and a history of a procoagulant state or deep venous thrombosis, anticoagulation may be indicated after weighing the risks of anticoagulation against potential benefits in preventing recurrent stroke. PFO closure does not guarantee the prevention of future stroke and should be addressed case by case, with consideration of patients for entry into ongoing clinical trials of safety, efficacy, and durability.
- Heart Disease and Stroke Statistics-2005 Update. Dallas, TX: American Heart Association; 2005.
- Petty GW, Brown RD, Whining JP, et al.: Ischemic stroke subtypes: a population based study of incidence and risk factors. Stroke 1999, 30:2513–2516. A population-based estimate of the magnitude of the underlying disorder.
- Woo D, Goebel J, Miller R, et al.: Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999, 30:2517–2522.
- Seib G: Incidence of patent foramen ovale cordis in adult American whites and American Negroes. Am J Anat 1934, 55:511–525. CrossRef
- Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clinic Proc 1984, 59:17–20.
- Meissner I, Whisnant JP, Khandheria BK, et al.: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999, 74:862–869. A unique, prospective population-based, longitudinal TEE study. CrossRef
- Meissner I: Outcome data from SPARC. J Am Coll Cardiol 2005, In press.
- Agmon Y, Khandheria BK, Meissner I, et al.: Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol 2001, 88:330–332. Population-based insights into the variability of PFO detection rates. CrossRef
- Hanley PC, Tajik AJ, Hynes JK, et al.: Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985, 6:1370–1382. CrossRef
- Agmon Y, Khandheria BK, Meissner I, et al.: Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999, 99:1942–1944. Nonreferral, population-based estimates of prevalence of ASA and its association with PFO.
- Albers GW, Comess KA, DeRook FA, et al.: Transesophageal echocardiographic findings in stroke subtypes. Stroke 1994, 25:23–28.
- Jeanrenaud X, Bogousslavsky J, Payot M, et al.: Patent foramen ovale and cerebral infarct in young patients [in French]. Schweiz Med Wochenschr 1990, 120:823–829.
- Ranoux D, Cohen A, Cabanes L, et al.: Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993, 24:31–34.
- Lechat P, Mas JL, Lascault G, et al.: Prevalence of patent foramen ovale in young stroke patients. Lancet 1988, 2:11–12.
- Di Tullio M, Sacco RL, Gopal A, et al.: Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461–465. Example of effect of nonpopulation-based study and controls, and of nonincident strokes, on study conclusions.
- de Beider MA, Tourikis L, Leech G, et al.: Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992, 69:1316–1320. CrossRef
- Cabanes L, Mas JL, Cohen A, et al.: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke 1993, 24:1865–1873.
- Labovitz AJ, Camp A, Castello R, et al.: Usefulness of transesophageal echocardiography in unexplained cerebral ischemia. Am J Cardiol 1993, 72:1448–1452. CrossRef
- Homma S, Di Tullio MR, Sacco RL, et al.: Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal echocardiographic study. Stroke 1994, 25:582–586.
- Petty GW, Khandheria BK, Chu CP, et al.: Patent foramen ovale in patients with cerebral infarction: a transesophageal echocardiographic study. Arch Neurol 1997, 54:819–822.
- Lindgren A, Roijer A, Norwing B, et al.: Carotid artery and heart disease in subtypes of cerebral infarction. Stroke 1994, 25:2356–2362.
- Roijer A, Lindfren A, Algotsson L, et al.: Cardiac changes in stroke patients and controls evaluated with transesophageal echocardiography. Scand CardiovascJ 1997, 31:329–337. A population-based study showing similar PFO prevalence in patients with stroke, compared with randomly selected community controls.
- Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172–1179. A meta-analysis illustrating the widely heterogeneous reporting of stroke risk with PFO.
- Meier B, Lock JE: Contemporary management of patent foramen ovale. Circulation 2003, 107:5–9. CrossRef
- MasJL, Arquizan C, Lamy C, et al.: Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. NEnglJMed 2001, 345:1740–1746. A substantially sized multicenter study evaluating stroke recurrence in patients with PFO, illustrating the controversies in management. CrossRef
- HommaS, Sacco RL, Di Tullio MR, et al.: PFO in Cryptogenic Stroke (PICCS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation 2002, 105:2625–2631. Results of a clinical trial evaluating aspirin versus warfarin in patients with PFO. CrossRef
- Messe SR, Silverman IE, Kizer Jr: Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 62:1042–1050. Evidence-based guidelines for management of patients with cryptogenic stroke, PFO, or ASA.
- Bogousslavsky J, Garazi S, Jeanrenaud X, et al.: Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Neurology 1996, 46:1301–1305.
- Homma S, Di Tullio MR, Sacco RL, et al.: Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997, 28:2376–2381.
- Dearani JA, Ugurlu BS, Danielson GK, et al.: Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999, 100(Suppl):II171-II175.
- Devuyst G, Bogousslavsky J, Ruchat P, et al.: Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MREI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996,47:1162–1166.
- Braun MU, Fassbender D, Schoen SP, et al.: Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002, 39:2019–2025. CrossRef
- Hung J, Landzberg MJ, Jenkins KJ, et al.: Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000, 35:1311–1316. CrossRef
- Windecker S, Wahl A, Chatterjee T, et al.: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000, 101:893–898.
- Martin F, Sanchez PL, Doherty E, et al.: Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002, 106:1121–1126. CrossRef
- Del Sette M, Angeli S, Leandri M, et al.: Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998, 8:327–330. CrossRef
- Anzola GP, Mangoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622–1625.
- Wilmhurst P, Nightingale S: Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci 2001, 100:215–220. CrossRef
- Lamy C, Giannesini C, Zuber M, for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group: Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale. The PFO-ASA Study. Stroke 2002, 33:706–711. CrossRef
- Post MC, Thijs V, Herroelen L, et al.: Closure of patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004, 62:1439–1440.
- Schwerzmann M, Wiher S, Nedeltchev K, et al.: Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 62:1399–1401.
- The management of patients with patent foramen ovale and stroke
Current Treatment Options in Neurology
Volume 7, Issue 6 , pp 483-490
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Author Affiliations
- 1. Department of Neurology, Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA